Skip to content
healthcare.dev

Tizanidine

NDC 71610-864, Tizanidine, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-864
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076416
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-864 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE4 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
71610-864-16716100864166000 TABLET in 1 BOTTLE (71610-864-16)
71610-864-307161008643030 TABLET in 1 BOTTLE (71610-864-30)
71610-864-537161008645360 TABLET in 1 BOTTLE (71610-864-53)
71610-864-607161008646090 TABLET in 1 BOTTLE (71610-864-60)
71610-864-75716100864757500 TABLET in 1 BOTTLE (71610-864-75)
71610-864-8071610086480180 TABLET in 1 BOTTLE (71610-864-80)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/25db7cc0-604c-3d6b-e063-6394a90a337f

Use it

Look up 71610-864 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-864 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-864. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.